Unit
- Definition and scope: Sterile compounding refers to the preparation of medications under controlled conditions to prevent contamination. It includes IV admixtures, TPN, chemotherapy, and ophthalmic preparations, all of which require a sterile environment to ensure patient safety.
- Historical context: Major contamination incidents, such as the 2012 fungal meningitis outbreak linked to a compounding pharmacy, prompted stricter regulations. Understanding these events highlights the gravity of management responsibilities in sterile compounding.
- Management responsibilities: Managers oversee facility design, staff training, environmental monitoring, documentation, and compliance. They act as the bridge between compounding personnel and regulatory bodies, ensuring all operations align with current standards.
- Key regulatory bodies: The United States Pharmacopeia (USP) sets standards for compounding; the FDA enforces drug quality; state boards of pharmacy license facilities. Managers must stay updated on changes from these entities.
- Risk levels in compounding: Low-risk, medium-risk, and high-risk preparations require different controls. For example, high-risk preparations like TPN must be compounded in an ISO Class 5 environment with additional testing.
- Role of the designated person: USP requires a designated person responsible for oversight. This individual ensures policies are followed, training is current, and deviations are investigated.
- Common terms: Aseptic processing, beyond-use date, cleanroom, ISO classification, laminar airflow workbench (LAFW), and primary engineering control (PEC). Managers must use these terms accurately in communication and documentation.
- Impact on patient outcomes: Proper sterile compounding management reduces infection rates, adverse drug events, and medication errors. A well-managed pharmacy improves patient trust and clinical outcomes.
- Personnel training and competency: Managers are responsible for implementing comprehensive training programs that cover aseptic technique, garbing procedures, and proper cleanroom behavior. Initial and annual competency assessments, including gloved fingertip and media fill tests, are crucial to verify that staff maintain the skills required for safe compounding.
- Environmental monitoring and control: Continuous monitoring of cleanroom parameters such as particle counts, pressure differentials, temperature, and humidity is a key managerial duty. Establishing appropriate action and alert limits for these parameters, along with a robust corrective action plan for excursions, helps maintain the integrity of the compounding environment.
- Beyond use dates and stability: Managers must establish policies for assigning beyond use dates based on USP standards and available stability data. This includes overseeing the proper labeling of compounded preparations and ensuring that preparations are not administered beyond their assigned date, preventing patient exposure to degraded or contaminated medications.
Scope of Practice
Role: Sterile Compounding Manager in a Hospital Pharmacy
Within scope:
- Developing and enforcing sterile compounding policies and procedures based on USP and .
- Scheduling and overseeing environmental monitoring of cleanrooms and PECs.
- Conducting or delegating staff training on aseptic technique and garbing procedures.
- Reviewing compounding records for accuracy and completeness.
- Investigating and documenting deviations or contamination events.
Outside scope:
- Personally performing sterile compounding on a routine basis (unless during training or emergency).
- Diagnosing patient conditions or prescribing medications.
- Altering beyond-use dates without appropriate stability data.
- Overriding environmental alarm setpoints without proper validation.
- Approving new compounding procedures without regulatory review.
Quick Revision
- Sterile compounding management ensures safe medication preparation through oversight of facilities, staff, and processes.
- Historical contamination incidents underscore the need for stringent management practices.
- Managers coordinate compliance with USP, FDA, and state regulations.
- The designated person holds ultimate accountability for sterile compounding operations.
- Understanding risk levels helps managers allocate resources appropriately.